Oral Presentation

[27V09-pm] 受容体・チャネル・トランスポーター、細胞内情報伝達

Sat. Mar 27, 2021 3:39 PM - 5:27 PM [Room V09] Oral Presentation 9 (Online)

座長：山村寿男（名市大院薬）、坪田真帆（近畿大薬）

+Add all to schedule

3:39 PM - 3:51 PM

[27V09-pm12S] Role of ezrin on plasma membrane trafficking of aquaporin-5

○Shin-ichi Muroi¹, Yoichiro Isohama¹ (1. Appl. Pharm., Fac. Pharm. Sci., Tokyo Univ. of Sci.)

3:51 PM - 4:03 PM

[27V09-pm13S] Functional analysis of In vivo metal transporter ZIP14 :
Development of metal-signal analysis system and treatment for cancer cachexia

○Yasuno Nakai¹, Takafumi Hara¹, Takanori Kunitake¹, Siho Nakano¹, Ayaka Noguchi¹, Emi Yoshigai¹, Mitchell D. Knutson², Toshiyuki Fukada¹ (1. Fac. Pharm. Sci., 2. FSHN Univ. FL.)

4:03 PM - 4:15 PM

[27V09-pm14S] Pathophysiological contribution of a macromolecular complex of the cardiac KCNQ1 channel

○Riki Inada¹, Masami Kodama², Yasuhiro Yamazaki¹, Kazuho Sakamoto¹, Junko Kurokawa¹ (1. Sch. Pharmaceut. Sci, University of Shizuoka, 2. IQB, The University of Tokyo)

4:15 PM - 4:27 PM

[27V09-pm15S] Opening of intermediate conductance Ca²⁺-activated K⁺ channels in C2C12 skeletal muscle cells increases the myotube diameter

○Chihiro Hibi¹, Kazuho Sakamoto¹, Syunya Takeshita¹, Junko Kurokawa¹ (1. Sch. Pharm. Sci., Univ. Shizuoka.)

4:27 PM - 4:39 PM

[27V09-pm16S] The evaluation of suppressing human prostate cancer proliferation via androgen receptor by azolato-bridged dinuclear platinum (Ⅱ) complexes

○Tasuku Arai¹, Maya Kamao², Seiji Komeda³, Yoshihisa Hirota^1,4 (1. Syst. Eng. and Sci., Grad. Sch. of Eng. and Sci., Shibaura Inst. Tech., 2. Ext. Cent., Kobe Pharm. Univ., 3. Fac. Pharm. Sci., Suzuka Univ. Med. Sci., 4. Coll. Med., Univ., Cincinnati)

4:39 PM - 4:51 PM

[27V09-pm17S] A G12-coupled DREADD for unraveling GPCR-signal-mediated T cell immunity

○Shiho Furukawa¹, Yuki Ono¹, Aska Inoue¹ (1. Grad. Sch. Of Pharm. Sci., Tohoku Univ.)

4:51 PM - 5:03 PM

[27V09-pm18] The cell cycle regulation networks and the therapeutic targets in RNA virus infection.

○Shihori Tanabe¹, Sabina Quader², Ryuichi Ono³, Horacio Cabral⁴, Kazuhiko Aoyagi⁵, Akihiko Hirose¹, Hiroshi Yokozaki⁶, Hiroki Sasaki⁷ (1. Div. Risk Assess., CBSR, Natl. Inst. Health Sci., 2. iCONM, 3. Div. Cell. Mol. Tox., CBSR, Natl. Inst. Health Sci., 4. Grad. Sch. Engineer., The Univ. of Tokyo, 5. Dept. Clin. Genomics, FIOC, Natl. Cancer Ctr. Res. Inst., 6. Grad. Sch. Med., Kobe Univ., 7. Dept. Transl. Oncol., FIOC, Natl. Cancer Ctr. Res. Inst.)

5:03 PM - 5:15 PM

[27V09-pm19S] Molecular mechanisms underlying µ-opioid receptor agonist-induced adverse effects

○Suzune Hiratsuka¹, Kouki Kawakami¹, Misaki Yoshida¹, Junken Aoki^2,3, Asuka Inoue^1,3 (1. Grad. Sch. of Pharm. Sci., Tohoku Univ, 2. Grad. Sch. of Pharm. Sci., Univ. of Tokyo, 3. LEAP, AMED)

5:15 PM - 5:27 PM

[27V09-pm20] Thiazolidinediones Downregulate PPARγ expression via Induction of aP2 During Mouse 3T3-L1 Preadipocyte Differentiation

○Atsuko Masumi¹, Kohei Moriyama¹, Ikumi Aizu¹, Yuko Oba¹, Marina Tonosaki¹ (1. Dept. Mol.Pharmacol. Pharm. Sci., Aomori Univ.)

Session information